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Abstract
Evaluation of strategies to ensure evidence-based, low-cost interventions reach those in need is
critical. One approach is to measure the strength, or intensity, with which packages of interventions
are delivered, in order to explore the association between implementation strength and public
health gains. A recent systematic review suggested methodological guidance was needed. We
described the approaches used in three examples of measures of implementation strength in
evaluation. These addressed important public health topics with a substantial disease burden in
low-and middle-income countries; they involved large-scale implementation; and featured evalu-
ation designs without comparison areas. Strengths and weaknesses of the approaches were dis-
cussed. In the evaluation of Ethiopia’s Health Extension Programme, implementation strength scor-
ing for each kebele (ward) was based on aggregated data from interviews with mothers of children
aged 12–23 months, reflecting their reports of contact with four elements of the programme. An
evaluation of the Avahan HIV prevention programme in India used the cumulative amount of
Avahan funding per HIV-infected person spent each year in each district. In these cases, a single
measure was developed and the association with hypothesised programme outcomes presented.
In the evaluation of the Affordable Medicines Facility—malaria, several implementation strength
measures were developed based on the duration of activity of the programme and the level of imple-
mentation of supporting interventions. Measuring the strength of programme implementation and
assessing its association with outcomes is a promising approach to strengthen pragmatic impact
evaluation. Five key aspects of developing an implementation strength measure are to: (a) develop a
logic model; (b) identify aspects of implementation to be assessed; (c) design and implement data
collection from a range of data sources; (d) decide whether and how to combine data into a single
measure; and, (e) plan whether and how to use the measure(s) in outcome analysis.
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Background
In low-and middle-income settings, weak health care systems are com-
mon (Mills 2004), and the gap between knowledge of proven interven-
tions and routine practice is wide. For example, in the 75 countries
which account for 95% of annual global maternal and child deaths,
just 62% of births have a skilled attendant, 26% of babies have post-
natal care within 2 days, and only 42% of children with suspected
pneumonia receive antibiotic treatment (Countdown to 2015, 2013).
Identifying successful implementation approaches is essential to help
ensure that evidence-based, low-cost interventions reach those in need.
Evaluations of strategies to improve public health are conducted for
multiple reasons including impact evaluation, course correction and ac-
countability to donors (Bryce et al. 2005; Horton et al. 2008). It may be
important to know which interventions can be delivered at scale; how
to optimize these in a new setting; and whether scale-up efforts result in
public health gains. Randomized trials and plausibility studies (Habicht
et al. 1999) based on a comparison of changes over time in both inter-
vention and comparison areas may not be feasible. One evaluation ap-
proach is to measure the strength or intensity with which packages of
interventions are delivered as they are rolled out, with a view to explor-
ing the association between implementation strength and public health
gains (Victora et al. 2011; Schellenberg et al. 2012). For this purpose a
measure of implementation strength might ideally range from zero to
the level sufficient to achieve a specified change in either intervention
coverage or in health outcomes in a particular context (Schellenberg
et al. 2012). An impact evaluation might assess whether and how
changes in health outcomes vary by implementation strength. Evidence
of an association between an improvement in health outcomes and im-
plementation strength could provide evidence that the improvement in
outcomes is due to the programme. Such an assessment might form ei-
ther the primary analysis strategy, or an approach complementary to
other approaches such as before–after studies, or as a secondary ana-
lysis conducted within a trial.
The term ‘implementation strength’ has been used interchange-
ably with ‘implementation intensity’ and is defined here as a quanti-
tative measure of the amount of input to, or activity to support, the
implementation of a programme. This is related to, but differs from,
the concept of intervention fidelity. Fidelity relates to the degree to
which a specified intervention or programme is delivered as planned,
e.g. as documented in a research protocol or programme document
(Carroll et al. 2007). Although there is common ground in the con-
cepts of fidelity and strength, our focus here is less on whether im-
plementation realities match up to pre-defined plans, and more on
documenting the strength of implementation put in place in practice.
In further contrast to implementation fidelity, in some research de-
signs implementation strength might be deliberately intended to
vary from one place to the next.
Implementation strength is an appealing concept, yet it can be
unclear how to put it into practice. A systematic review of 25 studies
identified 3 common approaches (Schellenberg et al. 2012). Some
authors developed scales with detailed descriptors of absolute levels
of implementation (e.g. ‘2 h of contact per week’). Others developed
relative strength scores often converted to a percentage scale.
Finally, some scales identified whether particular aspects of a pro-
gramme were in place and to what extent. A major conclusion of the
review was that more guidance was required in this area. In this art-
icle, we reflect on three studies, none of which were included in the
review. Two of these studies come from work with which our au-
thor group had been directly involved (Tougher et al. 2012; Karim
et al. 2013), while the third came from a study that we had previ-
ously appraised (Ng et al. 2011). We reflect on how measures of im-
plementation strength had been used in these large-scale programme
evaluations. We explore the advantages and disadvantages of the
approaches and in discussion offer guidance for how measures of
implementation strength could be developed in the future.
Methods
We focused on three case study evaluations that addressed import-
ant public health topics that carry a substantial morbidity and mor-
tality burden in low- and middle-income countries. They all
involved large-scale implementation and featured evaluation designs
without comparison areas. For each we identified the questions ad-
dressed by the evaluations and developed our own simple logic
model to describe our understanding of the intended pathway be-
tween the intervention package and its intended outcomes (WHO
2007; Bryce et al. 2011). We distinguished between inputs, proc-
esses, outputs, outcomes and impacts. For example, ‘inputs’ such as
money, medicines and health staff together with ‘processes’ such as
training health staff to use the medicines or mass media to promote
use of services might have been intended to lead to ‘outputs’ such as
utilization of health services by patients in need and ‘outcomes’ such
as sick children correctly treated and ‘impact’ such as lives saved.
Typically, implementation strength measures captured information
on inputs and/or processes while programme effect measures related
to outputs, outcomes or impacts.
We identified the main measure(s) of implementation strength
used by the authors, and describe the data collection approach de-
ployed and how the implementation strength measures were de-
veloped. Finally, we identified how the relationship between
implementation strength and public health outcomes was investi-
gated, or (in one case) why this was judged not to be possible. Since
outcomes and impacts are usually affected by issues other than the
programme under study, impact analysis will also require
Key Messages
• Measuring the strength of programme implementation and assessing its association with outcomes is a promising ap-
proach to strengthen pragmatic impact evaluation, both to assess impact and to identify which aspects of a programme
need to be strengthened.
• We suggest a five-step approach for developing a measure of implementation strength: (a) develop a logic model; (b)
identify the aspects of implementation to be assessed; (c) design and implement data collection from a range of data
sources; (d) decide whether and how to use a single measure; and (e) plan whether and how to use the measure in
statistical analysis.
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measurement and adjustment for contextual factors that change
over time and that might act as potential confounders or modifiers
of the relationship between implementation strength and pro-
gramme effects. Although we describe and reflect on the approaches
used in the case studies for this purpose, it was not our aim in this
article to critically appraise the overall study designs, assess the po-
tential for bias through uncontrolled confounding in each specific
example, or appraise the approaches used to control confounding.
Rather our aim was to focus on the development and use of the
measures of implementation strength.
Results
Table 1 provides a summary of the three cases.
Case Study 1: Evaluation of the effect of outreach activities through
Ethiopia’s health extension programme on maternal and newborn
care practices, Karim et al. (2013).
Overview of intervention
Ethiopia’s health extension programme was launched in 2003 with
the aim of providing universal access to primary health care services,
particularly preventive care, through over 34 000 female salaried
health extension workers (HEWs). Two HEWs in each ‘kebele’
(ward) served around 5000 people, and spent 75% of their time on
outreach activities: household visits, educating families to adopt
healthy behaviours and serve as ‘model families’ in their area, and
organizing others to participate in health extension programme ser-
vices. Volunteers drawn from ‘model family’ households supported
the HEWs by promoting health messages in the community.
Promoted child survival strategies included immunization, vitamin
A, oral rehydration therapy, malaria prevention through treated
mosquito nets and nutrition education. Although promotion of es-
sential newborn care including clean childbirth, cord care, thermal
care, immediate and exclusive breastfeeding and extra care for low-
birthweight babies was part of the health extension programme,
prior to 2009 the HEWs had no relevant skills in this area. In 2009
the ‘Last 10 km’ project (The Last Ten Kilometers Project. http://
l10k.jsi.com/, accessed 11 March 2015) introduced a programme to
give HEWs skills and tools to promote essential newborn care
practices in 101 ‘woredas’ (districts), with a population of around
11.6 million people, 16% of Ethiopia’s population. Figure 1 shows
a simplified logic model for one of the maternal and newborn care
practices, initiating breastfeeding immediately after birth, a practice
which has been shown to save lives (The Partnership for Maternal
NCH 2011).
Evaluation design
This study evaluated the effect of the health extension programme’s
outreach activities on maternal and newborn care practices at house-
hold level, through an assessment of whether changes over time in
care practices varied by the intensity of the health extension pro-
gramme’s outreach activities. The evaluation used a before–after
comparison in 101 woredas, comparing household maternal and
newborn care knowledge and practices at baseline (2008) with those
reported 2 years later (2010). In further analysis, changes from base-
line in care practices in kebeles with relatively low programme inten-
sity were compared with changes from baseline in kebeles with
relatively high programme intensity.
Definition and measurement of implementation strength
Implementation strength was expressed as ‘programme intensity’ and
gave a measure of exposure to the health extension programme ser-
vices. The implementation strength score was developed for each
‘kebele’ from interviews with mothers of children aged 12–23 months,
whereas household, maternal and newborn care knowledge and prac-
tices were assessed in women with a child aged 0–11 months.
Implementation strength scoring was based on four outreach activ-
ities: (a) %age of women reporting household visits by HEWs in the 6
months prior to the survey; (b) %age of women reporting household
visits by community volunteers in the 6 months prior to the survey; (c)
the proportion of families with a family health card; and (d) the pro-
portion of households that were either ‘model families’, or were work-
ing towards ‘model family’ status. The data were combined and a
score was calibrated to range between 0 and 10, with a higher score
indicating greater strength of implementation.
Association of implementation strength with outcomes
Between baseline and endline surveys, the percentage of mothers
who had initiated breastfeeding immediately after birth increased by
Table 1. Five steps in developing and using an implementation strength measure in impact evaluation studies, illustrated with three case
study examples
HEW Programme, Ethiopia Avahan, India Affordable Medicines
Facility—malaria, multi-country
1. Develop a Logic Model See Figure 1 See Figure 2 See Figure 3
2. Identify aspects of imple-
mentation strength to be
measured
Strength of health extension pro-
gramme’s outreach activities





3. Data collection Surveys with mothers (independ-
ent of outcome assessment)
Accounting data Document review, key informant
interviews, accounting infor-
mation and provider survey
4. Develop measures Kebele-level score developed
from four indicators
District-level metric of cumula-
tive amount of Avahan fund-
ing per HIV-infected person
spent each year
Country-level assessments of
each aspect of implementation;
no attempt to combine in a sin-
gle score
5. Use in outcome analysis Secondary analysis correlated
with outcomes, adjusting for
measured potential
confounders
Primary analysis correlated with
outcomes, adjusting for meas-
ured potential confounders
No formal association with out-
comes attempted, but overall
patterns of implementation
and outcomes were compared
across countries
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an average of 8% points [95% confidence interval (CI): 5–12, from
46 to 54%]. This change over time could have been due to a secular
trend or to other health programmes. Analysis of implementation
strength showed that the increase was greater in areas with higher
implementation strength score, with a 10% point increase in imple-
mentation strength being associated with a 10% point increase in
the odds of immediate breastfeeding (95% CI: 1–20%, P¼0.017).
Other outcomes showed similar results.
Case Study 2: Evaluation of an HIV prevention initiative in India:
Ng et al. (2011).
Overview of intervention
Between 2003 and 2008, $258 million was invested in the Avahan ini-
tiative in India, with the aim of reducing transmission of HIV through
increased coverage of preventive interventions in high-risk groups.
These high-risk populations included female sex workers and their cli-
ents and partners, injecting drug users and truck drivers. Components
of the intervention included: safe-sex counselling through peer out-
reach; treatment of sexually transmitted infections; distribution of free
condoms; needle and syringe exchange; and advocacy and community
mobilization. The interventions were delivered by sub-contracted
non-governmental and community-based organizations, co-ordinated
by state-level implementing partners and a central team. Our simpli-
fied logic model for the initiative is shown in Figure 2. We focus below
on Ng et al.’s study which used one measure of the strength of
Avahan implementation to evaluate the impact of the programme.
Several other evaluations of Avahan have been undertaken
(Ramakrishnan et al. 2010; Thilakavathi et al. 2011; Pickles et al.
2013) with wide variety in methods, geographic focus and outcomes,
but we focus on the Ng et al. article to illustrate the use of implemen-
tation strength for public health evaluation.
Evaluation design
The Avahan programme was not delivered with the same strength
across all of the six target Indian States, including after account-
ing for the number of people living with HIV in an area. Ng et al.
take advantage of this variation to estimate the impact of the pro-
gramme. They used regression methods to assess how variation
in implementation strength was associated with trends in HIV
prevalence in the general population measured through ante-
natal-clinic based surveillance, adjusting for a range of potential
confounding factors at the individual level. The approach did not
explicitly account for whether or not the Avahan programme was
the sole provider of services in the districts in which it was
implemented.
Definition and measurement of implementation strength
Using programme and demographic data the measure of implemen-
tation strength was calculated as the cumulative amount of Avahan
funding per HIV-infected person spent each year in each district
over the period 2003–2008. This figure varied from $24 to $433 per
HIV-infected person.
Association of implementation strength with outcomes
Ng et al. (2011) concluded that in the Southern states, where the
HIV epidemic was largely concentrated in high-risk sexual net-
works, every $100 increase in Avahan investment was associated
with an 18% (95% CI: 4–32%) reduction in the odds of HIV infec-
tion. The effect of Avahan seemed to be less pronounced in the
Northeastern states, where the HIV epidemic was concentrated in
networks of people who inject drugs, and where a $100 increase in
Avahan investment was associated with a 4% (95% CI: 6 to 14%)
reduction in the odds of HIV infection.
Figure 2. Simplified logic model for the effect of the Avahan initiative on HIV prevention in India at the district level.
Figure 1. Simplified logic model for the effect of Ethiopia’s health extension programme services on early initiation of breastfeeding.
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Case Study 3: Evaluation of the Affordable Medicines Facility—mal-
aria (AMFm), Tougher et al. (2012).
Overview of intervention
The AMFm aimed to improve treatment for uncomplicated malaria.
AMFm was hosted by the Global Fund to Fight AIDS, Tuberculosis
and Malaria (the Global Fund) and designed to improve access to
and use of quality-assured artemisinin combination therapies
(ACTs). The programme was launched in 2010 through eight na-
tional-scale pilots—Ghana, Kenya, Madagascar, Niger, Nigeria,
Tanzania mainland, Uganda and Zanzibar—and included providers
of antimalarials in all sectors (public, not-for-profit and for-profit).
There were three main components: negotiations with manufac-
turers to reduce factory prices; subsidy of quality-assured ACTs
through a co-payment mechanism; and supporting interventions
to encourage appropriate use. The co-payment mechanism meant
that approved importers could purchase ACTs from approved
manufacturers, at between 1 and 20% of the re-negotiated factory
price, with the balance paid to the manufacturer by the AMFm co-
payment fund. Once medicines arrived in-country they were distrib-
uted to end users through standard public and private distribution
channels. Supporting interventions in each country included com-
munication campaigns, recommended retail prices, provider train-
ing, and strengthening of regulation and pharmacovigilance. All
pilots had equal access to the benefits of price negotiations with
manufacturers and the establishment of the co-payment mechanism
at the Global Fund. Our simplified logic model for AMFm is pre-
sented in Figure 3.
Evaluation design
Tougher et al.’s (2012) independent evaluation of AMFm reported
the effect of the strategy on prices, availability and market share of
quality-assured ACTs, and coverage of appropriate antimalarial
treatment at the community level. They used a non-experimental de-
sign, based on pre–post comparisons, with baseline and endline 1
year apart. Control areas were not possible because implementation
was on a national scale. Outcome results were assessed against a set
of pre-defined success metrics.
Definition and measurement of implementation strength
The evaluation included a detailed documentation of implementa-
tion process and context through document review and key inform-
ant interviews, to facilitate interpretation and attribution of study
outcomes. At the outset, this component was intended to be primar-
ily qualitative, but during the analysis phase the utility of having
quantitative measures of implementation intensity was recognized,
both to summarize implementation experience and provide compar-
able estimates across countries.
The evaluators derived quantitative measures of implementation
at the country level based on duration and on implementation of
supporting interventions at the time of endline data collection
(Willey et al. 2014). Duration was felt to be particularly important
as the endline evaluation was conducted only 6–15 months after
implementation began. The implementation strength measures com-
prised number of months for which subsidized ACT was available
in-country (which ranged from 7 to 15.5 months), months for which
communication campaigns were implemented (0–9 months), dis-
bursements for supporting interventions (0.03–0.42 USD per capita)
and the proportion of private for-profit providers surveyed at
endline who reported being trained on antimalarials with the
AMFm symbol (2–50%) (Willey et al. 2014). Other potential facets
of implementation strength were considered, including the role of
stakeholders in facilitating the operation of the AMFm order system
and the quality of communications and training, but were less amen-
able to measurement.
Association of implementation strength with outcomes
There was clear variation in the success of countries in achieving
pre-specified benchmarks (Tougher et al. 2012). In summary, the
largest changes were seen in Ghana and Kenya, followed by
Zanzibar and Tanzania mainland. Performance in Nigeria and
Uganda was not consistent across outcomes, and limited impact was
observed in Niger and Madagascar.
Unlike in the other examples, Tougher et al. (2012) made no at-
tempt to do formal statistical analysis of the association between the
measure of implementation strength and outcomes. However, the
distribution of the implementation strength broadly mirrored the
relative performance of the pilots in terms of AMFm outcomes.
Ghana and Kenya were considered to have had the strongest
implementation, followed by Tanzania mainland, Zanzibar and
Nigeria. Niger, Madagascar and Uganda were considered to have
the lowest intensity of implementation. This also fed into an assess-
ment of whether changes in outcomes could be attributed to AMFm,
as the implementation strength analysis increased plausibility that
the large changes seen in some countries were attributable to
AMFm.
Figure 3. Simplified logic model for the effect of the AMFm on improved malaria treatment.
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Discussion
Measuring the strength of implementation of a programme and cor-
relating this with health or other outcomes is a promising approach
to pragmatic impact evaluation and is increasingly being used, but
methodological guidance is needed. We have described three ex-
amples in which measures of implementation strength have been
used. In this discussion, we reflect on five aspects of the development
and use of these measures and identify some of the potential
strengths and weaknesses of the approaches taken.
We suggest that the first step in developing a measure of imple-
mentation strength should be to develop an appropriate logic model
for the intervention. To illustrate our examples we have described
our own simplified logic models for the interventions presented, de-
veloped from information provided in the articles. In practice these
models would be much more detailed, and the authors of each of
our cited examples would have planned their work on the basis of
such models. Approaches such as theory of change (De Silva et al.
2014) may also be helpful and more amenable to reflecting complex
feedback loops, as can consideration of health system building
blocks and how they inter-relate in considering inputs and processes
(WHO 2007; Adam and de Savigny 2012). We have found the ap-
proximate separation of ‘implementer-controlled’ inputs and proc-
esses from the effects of these on services and target populations
(outputs, outcomes, impacts) to be especially helpful in this work
(Institute for International Programmes 2011).
The second step is to identify those aspects of implementation to be
assessed, guided by the logic model. For example, in Avahan a simple,
distal measure (dollars spent per HIV-positive person) was used as the
implementation strength variable. Money spent has both advantages
and disadvantages as a measure of implementation strength.
Advantages include that it is relatively simple to assess and should be
calculable from programme records. Investigators do not need to make
decisions about how to combine information from diverse programme
components. Money spent is well aligned to questions of cost-effective-
ness and value for money that is primary concerns for policy-makers.
One disadvantage is that money alone does not include informa-
tion on what the money was spent on, and whether it leads to im-
provements in service quality, accessibility or acceptability.
The Avahan model was based on innovation, efficiency and context-
specific tailoring of the delivery of a core package of services. In this
context, expenditure may not characterize the intended intensity
of appropriate services. Without other data, one cannot answer
questions of scalability of different components of the intervention
package, nor assess which components are likely to be the most im-
portant for effectiveness. Evaluations using money spent as a meas-
ure of implementation strength will benefit from additional study of
processes or outputs, otherwise the evaluation runs the risk of hav-
ing a ‘black box’ approach. It should be noted that other evaluations
of the Avahan programme have developed measures of processes
and outputs (Verma et al. 2010; Thilakavathi et al. 2011).
Another disadvantage is that low-intensity spending might partly
reflect the availability of services from other providers. Avahan was
the not sole provider in many of the districts where it was delivered,
Government services were also available. The estimated ‘effect’
of increasing the intensity of spending might reflect the effect of
increased Avahan spending where Avahan is already delivered, or
might reflect the replacement of Government services with Avahan.
The former (a dose-response relationship) and the latter (the effect
relative to Government services) could both support an effect of
Avahan, but the evaluation included the two effects in the overall ef-
fect estimate making the results hard to interpret.
In contrast to Avahan, the measures for AMFm focused on a mix
of ‘inputs’ and ‘processes’, and included the duration interventions
were in place (time since first arrival of subsidized drugs in-country
and duration of communications campaign), the money spent on
supporting interventions and a self-reported, provider-level measure
of exposure to AMFm-related training. The AMFm evaluation did
not include expenditure as a measure of implementation strength, al-
though expenditure on ACT subsidies can be considered a key input
(Figure 3). This reflected the demand driven nature of the interven-
tion—money in the co-payment fund was only spent when importers
from participating countries made orders, with such orders depend-
ing on their perceptions of in-country demand. The amount of
subsidized ACT ordered by each country varied considerably, with
the number of doses delivered per capita during the study period
ranging from 0.08 in Madagascar to 1.01 in Ghana. Order quanti-
ties were not under the control of the implementing agencies and
could thus be seen as a measure of performance of the intervention
in stimulating demand from importers and in the smooth running of
the ordering system. Similar challenges with using expenditure as a
measure of implementation strength would arise in other interven-
tions that have a demand-creation component. In the case of
Avahan it is possible that weaknesses in the services delivered in a
certain district would encourage increased funding, especially since
a large part of the innovation of the Avahan programme was to
have efficient real-time monitoring. Alternatively, efficient contrac-
tors may have been awarded additional funds as the quality of their
service delivery was evident in the monitoring.
The third step is to design and implement an appropriate data-
collection methodology to capture the dimension(s) of implementation
identified for measurement. It is important to consider the appropri-
ate level at which to measure (e.g. household, national), as well as the
most appropriate point in time for measurement (e.g. multiple time
points, baseline and endline only). Data-collection approaches will in-
evitably draw on a range of data sources. These might include account-
ing systems, quality assurance or monitoring and evaluation (M&E)
data, programme records, or surveys of providers. Data from intended
beneficiaries may also be included, but we caution that such measures
may reflect not just implementation strength but also the successful
coverage on the ground of such interventions, which may in fact be a
step further down the logic model. The method used to avoid such bias
in the Ethiopia Health Extension Worker study was to measure imple-
mentation strength at household level excluding the households of in-
tended beneficiaries. For example, large resources and effort might be
spent on establishing a complex in situ training regimen for health pro-
viders. In some places this may be implemented such that the number
of providers trained is high, while in other areas inefficiencies may
mean the number trained is low. In spirit a measure of implementation
strength may be more concerned with capturing the effort expended
than its success in achieving intended outputs (trained providers) since
this is itself a question of interest. In some situations, qualitative or par-
ticipatory data collection approaches might also be useful for assessing
implementation strength. Lessons learnt in the AMFm evaluation
included the importance of understanding context which had a major
role in determining relative performance. This was underlined by the
value of qualitative methods in understanding both process and context
alongside quantitative process measures to enable ranking by imple-
mentation strength.
In the fourth step, decisions must be made about whether and
how to use data on different aspects of implementation within a sin-
gle measure of implementation strength. In the Avahan example a
single variable, money per HIV-positive person, was assessed.
However, developing this into a district-level measure of
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implementation strength implicitly took account both of the length
of time the interventions were in place (since the total amount of
money spent in district was presumably influenced by the duration
of intervention) and the size of the target population. In the
Ethiopian example the implementation strength measure included
four different aspects of outreach work: two different types of home
visits, family health card ownership and the proportion of house-
holds with ‘model family’ status. These reflect a variety of aspects of
the programme, and a single score was derived to reflect overall
strength. In AMFm the approach was also multi-dimensional,
including data on money, time and proportion of the target popula-
tion trained. However, the AMFm study did not combine these
measures into a single index. We advise caution when combining
components from different areas of the logic model. Where indicators
are combined, choices will have to be made about the method used to
combine data, and implicitly or explicitly this will require consider-
ation of weighting. We suggest that these decisions should again
ideally be driven by theoretical concerns, e.g. the components
hypothesized to be most important, or most expensive might have
greater weights. Data-reduction approaches such as principal compo-
nents analysis may therefore be appropriate but should be approached
with care, to ensure the measure is readily understood. One limitation
in the measures developed for the Ethiopian programme was that the
composite index used to estimate implementation strength was com-
plex and unlikely to be have been readily understood by front-line im-
plementers. A different approach might be needed to reach decisions
on which aspects of the programme required strengthening. Other op-
tions include review and consensus, which will likely result in a meas-
ure with poorer mathematical and statistical properties but better
ownership and understanding from programme staff. Once a measure
is developed, some basic analysis of its properties, calibration and
cross-validation will be necessary. Common-sense checks that the de-
veloped measures correspond to realities on the ground in a small
number of locations are essential, and may want to be conducted dur-
ing the course of the study as well as at the end.
The fifth and final step is that decisions must be made about
how measures are used in analysis, ideally specified a priori in a stat-
istical analysis plan for the evaluation. This is beyond the remit of
this article, but it is worth noting that, using our examples, in
Avahan implementation strength was used as a primary exposure
measure, while in AMFm and the Ethiopian HEW case studies the
measure was used as supporting information to supplement the pri-
mary analysis. All three examples suggest that while development of
a robust measure of implementation strength had great value, it
does not address the potential for confounding when such measures
are correlated with health outcomes. The risk of bias from con-
founding in impact evaluations will need to be judged on a case-by-
case basis. In relation to the Ethiopian impact evaluation, the study
found strong evidence of a dose-response relationship between im-
plementation strength and better newborn care. However, other fac-
tors or programmes affecting the outcomes may have varied over
time as well as between kebeles, and without adjustment for these
factors the results could be biased in either direction. Contextual
factors also influenced AMFm outcomes, and also explained imple-
mentation strength itself. For example, the relatively poor imple-
mentation and performance in Niger and Madagascar reflected an
unfavourable political and economic context, and the nature of the
retail antimalarial market which was heavily dominated by unregis-
tered vendors which the authorities did not want to encourage to
stock ACT. Given these challenging contexts it is unclear whether
AMFm would have been effective in these pilots even if supporting
interventions had been fully implemented. Low implementation
strength and poor outcomes may be correlated because they both re-
flect limited local capacity, rather than because of a causal link be-
tween implementation strength and outcome.
Conclusion
Evaluation of public health strategies seeking to ensure that evi-
dence-based, low-cost interventions reach those in need is critical.
Robust measures of implementation strength for such strategies can
be a very useful component of an evaluation strategy, both to assess
impact and to identify which aspects of a programme need to be
strengthened. By reflecting on three approaches we have identified
five critical issues to be considered in guiding the development of
these measures in future evaluations.
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